TapewireFind a company

person · Reporting owner

Roberts David B

Disclosed activity across 2 companies

Tapewire entity
40132
SEC CIK
0001365731

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Anteris Technologies Global Corp.AVR · Entity 5089DirectorJune 07, 2026June 10, 2026
LEMAITRE VASCULAR INCLMAT · Entity 1927Director · President and DirectorSeptember 03, 2026September 08, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Anteris Technologies Global Corp.

Report date June 07, 2026 · Filed June 10, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect17,580 Reported balance After 2026-06-07 transaction · row 1
1 source row

Row 1 · 2026-06-07 · Exercise / conversion · Acquired 17,580 · Balance 17,580

F1: Each restricted stock unit ("RSU") converts into a share of common stock on a one-for-one basis.

Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect35,162 Reported balance After 2026-06-07 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2026-06-07 · Exercise / conversion · Disposed 17,580 · Balance 35,162

F1: Each restricted stock unit ("RSU") converts into a share of common stock on a one-for-one basis.

F2: On December 3, 2025, the reporting person was granted 52,742 RSUs that generally vest in approximately equal installments on June 7, 2026, June 7, 2027 and June 7, 2028, subject to the Reporting Person's continued service through each vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: Each restricted stock unit ("RSU") converts into a share of common stock on a one-for-one basis.

F2: On December 3, 2025, the reporting person was granted 52,742 RSUs that generally vest in approximately equal installments on June 7, 2026, June 7, 2027 and June 7, 2028, subject to the Reporting Person's continued service through each vesting date.

LEMAITRE VASCULAR INC

Report date September 03, 2026 · Filed September 08, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Dividend Equivalent RightsSEC Table II · derivative / convertible securityDirect25.4682 Reported balance After 2026-09-03 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2026-09-03 · Grant · Acquired 2.1262 · Balance 25.4682

F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Dividend Equivalent RightsSEC Table II · derivative / convertible securityDirect24.7852 Reported balance After 2026-09-03 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2026-09-03 · Grant · Acquired 2.1262 · Balance 24.7852

F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Dividend Equivalent RightsSEC Table II · derivative / convertible securityDirect30.34 Reported balance After 2026-09-03 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2026-09-03 · Grant · Acquired 3.6322 · Balance 30.34

F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Dividend Equivalent RightsSEC Table II · derivative / convertible securityDirect32.3815 Reported balance After 2026-09-03 transaction · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · 2026-09-03 · Grant · Acquired 4.3524 · Balance 32.3815

F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Dividend Equivalent RightsSEC Table II · derivative / convertible securityDirect17.5403 Reported balance After 2026-09-03 transaction · row 5 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 5 · 2026-09-03 · Grant · Acquired 3.1566 · Balance 17.5403

F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Dividend Equivalent RightsSEC Table II · derivative / convertible securityDirect18.6239 Reported balance After 2026-09-03 transaction · row 6 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 6 · 2026-09-03 · Grant · Acquired 3.5757 · Balance 18.6239

F6: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Dividend Equivalent RightsSEC Table II · derivative / convertible securityDirect1.9861 Reported balance After 2026-09-03 transaction · row 7 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 7 · 2026-09-03 · Grant · Acquired 0.3056 · Balance 1.9861

F7: These dividend equivalent rights accrued on a restricted stock unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Dividend Equivalent RightsSEC Table II · derivative / convertible securityDirect2.0893 Reported balance After 2026-09-03 transaction · row 8 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 8 · 2026-09-03 · Grant · Acquired 0.3453 · Balance 2.0893

F8: These dividend equivalent rights accrued on a performance share unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Dividend Equivalent RightsSEC Table II · derivative / convertible securityDirect13.6627 Reported balance After 2026-09-03 transaction · row 9 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 9 · 2026-09-03 · Grant · Acquired 5.2874 · Balance 13.6627

F9: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Filing footnotes · ownership attribution and instrument terms

F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F6: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F7: These dividend equivalent rights accrued on a restricted stock unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F8: These dividend equivalent rights accrued on a performance share unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F9: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
December 10, 2025 Filed Dec 11, 2025 23:09 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantStock Option (Right to Buy) · Derivative 10,400 $0.00 Strike: $83.66 $0.00
Disclosure

SEC source: 0001193125-25-316350 · ownership.xml · derivative · entry 2

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,400

Underlying: Common Stock · 10,400 shares

Expires 2032-12-10

F2 · derivative.exercise_date: This option is exercisable and vests over a four-year period at a rate of 25% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining three years.

Read SEC document
December 10, 2025 Filed Dec 11, 2025 23:09 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantCommon Stock 1,694 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-316350 · ownership.xml · nonDerivative · entry 1

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,091

F1 · shares: Represents a restricted stock unit award that vests on a time-based schedule as follows: 25% of the award vests on 12/1/2026, with the balance vesting in equal annual installments over the remaining three years. This award includes a provision for the withholding of shares by the Issuer to pay the withholding taxes due on each vesting date.

Read SEC document
December 08, 2025 Filed Dec 11, 2025 00:27 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionDividend Equivalent Rights · Derivative 11 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-314625 · ownership.xml · derivative · entry 6

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21.1353

Underlying: Common Stock · 11 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F5 · shares: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F5 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F5 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
December 08, 2025 Filed Dec 11, 2025 00:27 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionDividend Equivalent Rights · Derivative 9 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-314625 · ownership.xml · derivative · entry 5

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20.9544

Underlying: Common Stock · 9 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
December 08, 2025 Filed Dec 11, 2025 00:27 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Tax withholdingCommon Stock 205 $82.93 $17,000.65
Disclosure

SEC source: 0001193125-25-314625 · ownership.xml · nonDerivative · entry 4

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,397

F3 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of performance stock units awarded to the reporting person on 12/8/2023. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.

Read SEC document
December 08, 2025 Filed Dec 11, 2025 00:27 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionCommon Stock 11 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-314625 · ownership.xml · nonDerivative · entry 3

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,602

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

Read SEC document
December 08, 2025 Filed Dec 11, 2025 00:27 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Tax withholdingCommon Stock 230 $82.93 $19,073.90
Disclosure

SEC source: 0001193125-25-314625 · ownership.xml · nonDerivative · entry 2

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,591

F2 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on 12/8/2023. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.

Read SEC document
December 08, 2025 Filed Dec 11, 2025 00:27 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionCommon Stock 9 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-314625 · ownership.xml · nonDerivative · entry 1

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,821

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

Read SEC document
December 06, 2025 Filed Dec 9, 2025 01:32 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionDividend Equivalent Rights · Derivative 3 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-311619 · ownership.xml · derivative · entry 11

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9.3839

Underlying: Common Stock · 3 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F11 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/6/2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F11 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/6/2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F11 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/6/2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F11 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/6/2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
December 06, 2025 Filed Dec 9, 2025 01:32 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Tax withholdingCommon Stock 10 $84.53 $845.30
Disclosure

SEC source: 0001193125-25-311619 · ownership.xml · nonDerivative · entry 3

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,812

F3 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on 2/18/2025. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.

Read SEC document
December 06, 2025 Filed Dec 9, 2025 01:32 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Tax withholdingCommon Stock 99 $84.53 $8,368.47
Disclosure

SEC source: 0001193125-25-311619 · ownership.xml · nonDerivative · entry 2

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,822

F2 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on 12/6/2024. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.

Read SEC document
December 06, 2025 Filed Dec 9, 2025 01:32 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionCommon Stock 3 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-311619 · ownership.xml · nonDerivative · entry 1

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,921

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

Read SEC document
December 04, 2025 Filed Dec 9, 2025 01:32 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.3029 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-311619 · ownership.xml · derivative · entry 10

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1.1966

Underlying: Common Stock · 0.3029 shares

Expires not disclosed

F10 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F10 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F10 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
December 04, 2025 Filed Dec 9, 2025 01:32 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 3.1369 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-311619 · ownership.xml · derivative · entry 9

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12.3839

Underlying: Common Stock · 3.1369 shares

Expires not disclosed

F9 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F9 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F9 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
December 04, 2025 Filed Dec 9, 2025 01:32 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 4.8696 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-311619 · ownership.xml · derivative · entry 8

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32.1353

Underlying: Common Stock · 4.8696 shares

Expires not disclosed

F8 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F8 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F8 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
December 04, 2025 Filed Dec 9, 2025 01:32 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 4.0638 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-311619 · ownership.xml · derivative · entry 7

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29.9544

Underlying: Common Stock · 4.0638 shares

Expires not disclosed

F7 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F7 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F7 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
December 04, 2025 Filed Dec 9, 2025 01:32 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 3.1697 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-311619 · ownership.xml · derivative · entry 6

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37.291

Underlying: Common Stock · 3.1697 shares

Expires not disclosed

F6 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F6 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F6 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
December 04, 2025 Filed Dec 9, 2025 01:32 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 3.1697 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-311619 · ownership.xml · derivative · entry 5

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37.974

Underlying: Common Stock · 3.1697 shares

Expires not disclosed

F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
December 04, 2025 Filed Dec 9, 2025 01:32 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 1.5566 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-311619 · ownership.xml · derivative · entry 4

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26.9358

Underlying: Common Stock · 1.5566 shares

Expires not disclosed

F4 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
December 03, 2025 Filed Dec 5, 2025 23:30 UTC Anteris Technologies Global Corp. AVR · Entity 5089 GrantRestricted Stock Units · Derivative 13,821 $0.00 $0.00
Disclosure

SEC source: 0001140361-25-044605 · form4.xml · derivative · entry 2

Roberts David B · CIK 0001365731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,821

Underlying: Common Stock · 13,821 shares

Expires not disclosed

F2 · derivative.exercise_price: Each RSU represents a right to receive one share of common stock. These RSU vest on the earlier of the first anniversary of the grant date and the date of the next occurring annual stockholders meeting, subject to continued service through the vesting date.

F2 · derivative.exercise_date: Each RSU represents a right to receive one share of common stock. These RSU vest on the earlier of the first anniversary of the grant date and the date of the next occurring annual stockholders meeting, subject to continued service through the vesting date.

F2 · derivative.expiration_date: Each RSU represents a right to receive one share of common stock. These RSU vest on the earlier of the first anniversary of the grant date and the date of the next occurring annual stockholders meeting, subject to continued service through the vesting date.

Read SEC document
December 03, 2025 Filed Dec 5, 2025 23:30 UTC Anteris Technologies Global Corp. AVR · Entity 5089 GrantRestricted Stock Units · Derivative 52,742 $0.00 $0.00
Disclosure

SEC source: 0001140361-25-044605 · form4.xml · derivative · entry 1

Roberts David B · CIK 0001365731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,742

Underlying: Common Stock · 52,742 shares

Expires not disclosed

F1 · derivative.exercise_price: Each RSU represents a right to receive one share of common stock. These RSU vest in three approximately equal annual installments on June 7, 2026, 2027 and 2028, subject to the Reporting Person's continued service through each vesting date.

F1 · derivative.exercise_date: Each RSU represents a right to receive one share of common stock. These RSU vest in three approximately equal annual installments on June 7, 2026, 2027 and 2028, subject to the Reporting Person's continued service through each vesting date.

F1 · derivative.expiration_date: Each RSU represents a right to receive one share of common stock. These RSU vest in three approximately equal annual installments on June 7, 2026, 2027 and 2028, subject to the Reporting Person's continued service through each vesting date.

Read SEC document
December 02, 2025 Filed Dec 4, 2025 00:38 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionDividend Equivalent Rights · Derivative 15 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-307160 · ownership.xml · derivative · entry 3

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 2, 2020. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 2, 2020. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 2, 2020. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 2, 2020. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · balance_after: Fractional shares released (if any) on each vesting date were settled in cash, resulting in a final balance of zero.

Read SEC document
December 02, 2025 Filed Dec 4, 2025 00:38 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Tax withholdingCommon Stock 107 $83.68 $8,953.76
Disclosure

SEC source: 0001193125-25-307160 · ownership.xml · nonDerivative · entry 2

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,918

F2 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 2, 2020. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.

Read SEC document
December 02, 2025 Filed Dec 4, 2025 00:38 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionCommon Stock 15 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-307160 · ownership.xml · nonDerivative · entry 1

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,025

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

Read SEC document
September 04, 2025 Filed Sep 8, 2025 22:12 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.2669 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-028580 · rdgdoc.xml · derivative · entry 8

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0.8937

Underlying: Common Stock · 0.2669 shares

Expires not disclosed

F8 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F8 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F8 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
September 04, 2025 Filed Sep 8, 2025 22:12 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 2.7639 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-028580 · rdgdoc.xml · derivative · entry 7

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9.247

Underlying: Common Stock · 2.7639 shares

Expires not disclosed

F7 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F7 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F7 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
September 04, 2025 Filed Sep 8, 2025 22:12 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 4.2906 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-028580 · rdgdoc.xml · derivative · entry 6

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27.2657

Underlying: Common Stock · 4.2906 shares

Expires not disclosed

F6 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F6 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F6 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
September 04, 2025 Filed Sep 8, 2025 22:12 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 3.5808 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-028580 · rdgdoc.xml · derivative · entry 5

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25.8906

Underlying: Common Stock · 3.5808 shares

Expires not disclosed

F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
September 04, 2025 Filed Sep 8, 2025 22:12 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 2.7926 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-028580 · rdgdoc.xml · derivative · entry 4

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34.1213

Underlying: Common Stock · 2.7926 shares

Expires not disclosed

F4 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
September 04, 2025 Filed Sep 8, 2025 22:12 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 2.7926 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-028580 · rdgdoc.xml · derivative · entry 3

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34.8043

Underlying: Common Stock · 2.7926 shares

Expires not disclosed

F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
September 04, 2025 Filed Sep 8, 2025 22:12 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 1.3714 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-028580 · rdgdoc.xml · derivative · entry 2

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25.3792

Underlying: Common Stock · 1.3714 shares

Expires not disclosed

F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
September 04, 2025 Filed Sep 8, 2025 22:12 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.7211 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-028580 · rdgdoc.xml · derivative · entry 1

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17.1959

Underlying: Common Stock · 0.7211 shares

Expires not disclosed

F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
August 11, 2025 Filed Aug 13, 2025 21:08 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionStock Option (Right to Buy) · Derivative 6,713 $0.00 Strike: $37.29 $0.00
Disclosure

SEC source: 0001437749-25-026575 · rdgdoc.xml · derivative · entry 9

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,672

Underlying: Common Stock · 6,713 shares

Expires 2027-12-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years.

Read SEC document
August 11, 2025 Filed Aug 13, 2025 21:08 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionStock Option (Right to Buy) · Derivative 3,979 $0.00 Strike: $37.29 $0.00
Disclosure

SEC source: 0001437749-25-026575 · rdgdoc.xml · derivative · entry 8

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,385

Underlying: Common Stock · 3,979 shares

Expires 2027-12-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years.

Read SEC document
August 11, 2025 Filed Aug 13, 2025 21:08 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionStock Option (Right to Buy) · Derivative 123 $0.00 Strike: $35.48 $0.00
Disclosure

SEC source: 0001437749-25-026575 · rdgdoc.xml · derivative · entry 7

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 123 shares

Expires 2026-12-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: This option is fully vested and exercisable.

Read SEC document
August 11, 2025 Filed Aug 13, 2025 21:08 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 SaleCommon Stock 6,713 $92.35 $619,978.44
Disclosure

SEC source: 0001437749-25-026575 · rdgdoc.xml · nonDerivative · entry 6

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,976

F4 · shares: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $92.045 to $93.04. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.

Read SEC document
August 11, 2025 Filed Aug 13, 2025 21:08 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionCommon Stock 6,713 $37.29 $250,327.77
Disclosure

SEC source: 0001437749-25-026575 · rdgdoc.xml · nonDerivative · entry 5

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,689

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.

Read SEC document
August 11, 2025 Filed Aug 13, 2025 21:08 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 SaleCommon Stock 384 $91.55 $35,154.59
Disclosure

SEC source: 0001437749-25-026575 · rdgdoc.xml · nonDerivative · entry 4

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,976

F3 · shares: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $91.38 to $91.89. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.

Read SEC document
August 11, 2025 Filed Aug 13, 2025 21:08 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 SaleCommon Stock 3,718 $92.53 $344,040.30
Disclosure

SEC source: 0001437749-25-026575 · rdgdoc.xml · nonDerivative · entry 3

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,360

F2 · shares: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $91.91 to $92.91. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.

Read SEC document
August 11, 2025 Filed Aug 13, 2025 21:08 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionCommon Stock 123 $35.48 $4,364.04
Disclosure

SEC source: 0001437749-25-026575 · rdgdoc.xml · nonDerivative · entry 2

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,078

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.

Read SEC document
August 11, 2025 Filed Aug 13, 2025 21:08 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionCommon Stock 3,979 $37.29 $148,376.91
Disclosure

SEC source: 0001437749-25-026575 · rdgdoc.xml · nonDerivative · entry 1

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,955

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 20:17 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.3193 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-019159 · rdgdoc.xml · derivative · entry 8

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0.6268

Underlying: Common Stock · 0.3193 shares

Expires not disclosed

F8 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F8 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F8 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 20:17 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 3.3015 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-019159 · rdgdoc.xml · derivative · entry 7

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6.4831

Underlying: Common Stock · 3.3015 shares

Expires not disclosed

F7 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F7 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F7 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 20:17 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 5.1249 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-019159 · rdgdoc.xml · derivative · entry 6

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22.9751

Underlying: Common Stock · 5.1249 shares

Expires not disclosed

F6 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F6 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F6 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 20:17 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 4.2768 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-019159 · rdgdoc.xml · derivative · entry 5

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22.3098

Underlying: Common Stock · 4.2768 shares

Expires not disclosed

F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 20:17 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 3.3357 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-019159 · rdgdoc.xml · derivative · entry 4

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31.3287

Underlying: Common Stock · 3.3357 shares

Expires not disclosed

F4 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 20:17 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 3.3357 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-019159 · rdgdoc.xml · derivative · entry 3

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32.0117

Underlying: Common Stock · 3.3357 shares

Expires not disclosed

F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 20:17 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 1.6382 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-019159 · rdgdoc.xml · derivative · entry 2

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24.0078

Underlying: Common Stock · 1.6382 shares

Expires not disclosed

F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 20:17 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.8606 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-019159 · rdgdoc.xml · derivative · entry 1

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16.4748

Underlying: Common Stock · 0.8606 shares

Expires not disclosed

F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
March 27, 2025 Filed Mar 31, 2025 21:14 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.3075 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-010269 · rdgdoc.xml · derivative · entry 8

Roberts David B · CIK 0001365731 · Director · President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0.3075

Underlying: Common Stock · 0.3075 shares

Expires not disclosed

F8 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F8 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F8 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.